The ALS Association

Research supported by The ALS Association in 2017 accelerated momentum toward treatments and a cure. Our grants-funded research led by top ALS scientists and clinicians; enrollment in ALS clinic trials is higher than ever; ALS drug development is taking off; assistive technology is advancing rapidly; and new biomarkers to track ALS progression and improve diagnosis are being discovered.

Here are the biggest research advances in 2017 – all funded by The ALS Association.

Clinical Trials and Studies


Assistive Technology

Our investments in assistive technology led to:

  • Key advances in wearable sensor and brain computer interface technology by our Assistive Technology Challenge winners; and
  • The development of exciting new assistive technology ideas by students during the ALS Hackathon.

Drug Development

  • Three organizations – Answer ALS, Project MinE, and New York Genome Center for Genomics of Neurodegenerative Disease (CGND) ALS Consortium began sharing genome sequencing information to speed efforts toward new ALS treatments and a cure.
  • The NYGC CGND expanded, launched a new clinical database, and made data from 2,500+ samples available to global researchers.
  • Aquinnah Pharmaceuticals’ stress granule research and the Neuro Collaborative Brain Bot project advanced through new pharma partnerships.

Breakthrough Prize in Life Sciences

ALS researcher Dr. Don Cleveland won the $3 million 2018 Breakthrough Prize in Life Sciences, allowing him to continue his work in ALS antisense technology. Successes of antisense therapy in other neurodegenerative diseases all stemmed from our initial investment in this work.

"I’m incredibly grateful to The ALS Association for their support – right from the beginning and continuing to today – that enabled the success that is now being celebrated."
– Dr. Don Cleveland


Biomarkers


Basic Research

Research in 2017 provided:


ALS Association News


For more detailed information on 2017 research advances we fund, please read our blog.

Share this Infographic


 

 

Powered by Blackbaud
nonprofit software